[1] |
Hell man S,Weichsel bau m R R,Oligo metastases.J Clin Oncol,1995,13:8-10.
|
[2] |
Tait C R,Water worth A,Loncaster J,et al.The oligometastatic state in breast cancer:hypothesis or reality.Breast,2005,14:87-93.
|
[3] |
Lud wing C,Stoelben E,Hasse J.Disease-free survival after resection of lung metastases in patient wit h breast cancer.Eur J Sur g Oncol,2003,29:532-535.
|
[4] |
Vlastos G,Smith D L,Singletary S E,et al.Long-ter msuvival after an aggressive surgical approach in patient with breast cancer hepatic metastases.Ann Surg Oncol,2004,11:869-874.
|
[5] |
Rades D,Veninga T,Stalpen L J,et al.Outcome after radiotherapy alone for metastatic spinal cord compression in patient with oligometastases.J Clin Oncol,2007,25:50-56.
|
[6] |
Durr H R,Muller P E,Lenz T,et al.Surgical treat ment of bone metastases in patients with breast cancer.Clin Orthop,2002,396:191-196.
|
[7] |
Paget S.The distribution of secondary growths in cancer of the breast.Lancet,1889,1:571-573.
|
[8] |
Weinber g R A.Mechanis ms of malignant pr ogression.Carcinogenesis,2008,29:1092-1095.
|
[9] |
otiriou C,Pusztai L.Gene-expression signat ure in breast cancer.N Engl J Med,2009,360:790-800.
|
[10] |
Demicheli R.Tumour dor mancy:findings and hypotheses from clinical research on breast cancer.Semin Cancer Biol,2001,11:297-305.
|
[11] |
ac Der med D M,Weichselbau m R R,Salama J K.A rationale for the targeted of oligo metastases with radiotherapy.J Surg Oncol,2008,98:202-206.
|
[12] |
parano J A,Paik S.Develop ment of the 21-gene assay and its application in clinical practice and clinic trials.J Clin Oncol,2008,26:721-728.
|
[13] |
ardoso F,van't veer L,Rutgers E,et al.Clinical application of the 70-gene profile:the MINDACT trial.J Clin Oncol,2008,26:729-735.
|
[14] |
ies L A,Eisner M P,Cosar y C L,et al.Seer cancer statistics review 1975-2002.Bet hesda,MD,National Cancer Institute.http://seer.cancer.gov/csr/1975-2002.
|
[15] |
inn A J,Gupta G P,Siegel P M,et al.Genes t hat mediate breast cancer metastasis to l ung.Nature,2005,436:518-524.
|
[16] |
Milano M T,Kats A W,Muhs A G,et al.A prospective pilot study of curative-intent stereotactic body radiation t herapy in patients wit h 5 or fewer oligo metastatic lesions.Cancer,2008,112:650-658.
|
[17] |
odrigues L R,Teixeira J A,Sch mi H F L,et al.The role of osteoportin in tu mor progression and metastasis in breast cancer.Cancer Epidemiol Bio mar kers Prev,2007,16:1087-1097.
|
[18] |
海滨,胡组建,胡望华.乳腺癌骨转移综合治疗初探.中华乳腺病杂志:电子版,2007,1:182.
|
[19] |
apiti E,Ver kooijen H M,Vlastos G,et al.Co mplete excision of pri mary breast tu mor i mpr oves sur vival of patients wit h metastatic breast cancer at diagnosis.J Clin Oncol,2006,24:2743-2749.
|
[20] |
ubin P,Brasacchio R,Katz A.Solitary metastases:ill usion versus reality.Semin Radiat Oncol,2006,16:120-130.
|
[21] |
radishar WJ,Bell on J R,Gtadd M A,et al.A 47-year-ol d wo man with a mass in t he breast and a solitary lesion in the spine.N Engl J Med,2008,359:1382-1391.
|
[22] |
reenber g P A C,Hortobagyi G N,Smit h T L,et al.Long-ter m f ollow up of patients wit h co mpletere mission f ollowing co mbination chemot herapy f or metastatic breast cancer.J Clin Oncol,1996,14:2197-2205.
|
[23] |
Khan S A,Stewart A K,Morrow M.Dose aggressive local therapy i mprove survival in metastatic breast cancer?Sur ger y,2002,132:620-626.
|
[24] |
lar ke M,Collins R,Dar by S,et al.Eff ects of radiotherapy and of differences in t he extent of surgery f or early breast cancer on local recurrence and 15-year survival:an overview of the rando mised trials.Lancet,2005,366:2087-2106.
|
[25] |
abiera G V,Rao R,Feng L,et al.Effects of pri mar y t u mor extir pation in breast cancer patients who present with stageⅣdisease and an intact pri mary tu mor.Ann Sur g Oncol,2006,13:776-782.
|
[26] |
lanchard D K,Shetty P B,Hilsenbeck S G,et al.Association of surgery with i mproved sur vival in stageⅣbreast cancer patients.Ann Sur g Oncol,2008,247:732-738.
|
[27] |
ristofanilli M,Hayes D F,Budd G T,et al.Circulating tumor cells:a novel prognostic factor for newly diagnosed metastatic breast cancer.J Clin Oncol,2005,23:1420-1430.
|
[28] |
ristofanilli M,Budd G T,Ellis M J,et al.Circulating tu mor cells,disease progression,and sur vival in metastatic breast cancer.N Engl J Med,2004,351:781-791.
|